Abiopharma

🔍 Le Pendeven Yves (Executive)

Company: Funko, Inc. (FNKO)

Report Date: 2026-08-07

Detailed Transactions and Holdings:

• Sold 13,138 shares of CLASS A COMMON STOCK at $7.0003 per share (Direct)
  Date: 2026-08-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 44,936.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 2,950 shares of CLASS A COMMON STOCK (Direct)
  Date: 2026-08-08 | Code: M | equity_swap_involved: 0 | shares_owned_after: 47,886.00 | transaction_form_type: 4 | Footnotes: F3
• Sold 1,117 shares of CLASS A COMMON STOCK at $6.0014 per share (Direct)
  Date: 2026-08-10 | Code: S | equity_swap_involved: 0 | shares_owned_after: 46,769.00 | transaction_form_type: 4 | Footnotes: F4, F5
• Sold 2,950 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-08 | Code: M | equity_swap_involved: 0 | shares_owned_after: 5,900.00 | transaction_form_type: 4 | Footnotes: F3, F6, F6

Footnotes:

• F1: Shares were sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 13, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
• F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.000 to $7.010, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
• F3: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A Common Stock or, at the election of the Issuer, an equivalent cash payment.
• F4: Shares were sold to cover taxes upon the vesting of restricted stock units pursuant to a Rule 10b5-1 sell to cover instruction dated June 14, 2023.
• F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.94 to $6.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
• F6: The original grant of 11,800 RSUs has vested or will vest in four equal installments on each of the first through fourth anniversaries of August 8, 2024, subject to the Reporting Person's continued employment with the Issuer through each applicable vesting date.